價格 | ¥18700 | ¥10500 | ¥13700 |
包裝 | 100mg | 25mg | 50mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-12 |
中文名稱:化合物 PF-06380101 | 英文名稱:PF-06380101 |
CAS:1436391-86-4 | 品牌: TargetMol |
產(chǎn)地: 美國 | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
產(chǎn)品類別: 抑制劑 | |
貨號: T16490 |
名稱 | PF-06380101 |
描述 | PF-06380101 is an auristatin microtubule inhibitor and is a cytotoxic Dolastatin 10 analogue. When compared to other synthetic auristatin analogues that are used in the preparation of ADCs, PF-06380101 displays excellent potencies in tumor cell proliferation assays and differential ADME properties. |
體內(nèi)活性 | PF-06380101 is anticipated to be of low risk to perpetrate pharmacokinetic drug interactions with compounds for which CYP1A2, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, and/or CYP3A4/5-mediated metabolism constitutes the primary mechanism of clearance. PF-06380101 preferentially distributes into human plasma relative to whole blood and that PF-06380101 is a P-glycoprotein (P-gp) substrate. PF-06380101 exhibited a mean systemic clearance (Cl) of 70 mL/min/kg and a volume of distribution (Vss) of 14.70 L/kg after an IV dose of 20a at 20 μg/kg to Wistar Han rats, resulting in a terminal elimination half-life (t1/2) of approximately 6 h. The utility of the new auristatin analogues as ADC payloads including the development of the lead analogue 20a (PF-06380101) will be reported in due course. |
存儲條件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度 | DMSO : 65 mg/mL (87.48 mM) |
關(guān)鍵字 | PF 06380101 | PF06380101 | PF-06380101 |
相關(guān)產(chǎn)品 | Fluticasone (propionate) | Doxorubicin hydrochloride | Aldoxorubicin hydrochloride | Dexamethasone acetate | Daunorubicin hydrochloride | Dexamethasone | Camptothecin | Paclitaxel | Budesonide | Exatecan | Methotrexate | Mertansine |
成立日期 | 2013-04-18 (12年) | 注冊資本 | 566.265100萬人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
---|---|---|---|---|
詢價 |
VIP2年
|
陜西西化化學(xué)工業(yè)有限公司
|
2024-07-24 | |
詢價 |
VIP3年
|
武漢英諾醫(yī)藥科技有限公司
|
2024-12-31 | |
¥56 |
VIP2年
|
浙江杰坤生物科技有限公司
|
2024-12-31 |